ONABOTULINUMTOXINA SIGNIFICANTLY IMPROVES URINARY INCONTINENCE AND QUALITY OF LIFE IN OVERACTIVE BLADDER PATIENTS REGARDLESS OF INCONTINENCE SEVERITY AT BASELINE

被引：0
|
作者：
Ginsberg, D. [1 ]
Gruenenfelder, J. [2 ]
Moore, C. [3 ]
Kaufmann, A. [4 ]
Drake, M. [5 ]
Joshi, M. [6 ]
Magyar, A. [7 ]
Herschorn, S. [8 ]
机构：
[1] USC Inst Urol, Los Angeles, CA USA
[2] Orange Cty Urol Associates, Laguna Hills, CA USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Kliniken Maria Hilf GmbH, Monchengladbach, Germany
[5] Bristol Urol Inst, Bristol, Avon, England
[6] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[7] Allergan Pharmaceut Inc, Bridgewater, NJ USA
[8] Univ Toronto, Toronto, ON, Canada
来源：
NEUROUROLOGY AND URODYNAMICS | 2015年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
167
引用
收藏
页码：S109 / S110
页数：2
相关论文
共 50 条
  • [1] OnabotulinumtoxinA reduces urinary incontinence and urgency and improves quality of life in patients with overactive bladder regardless of incontinence severity at baseline
    Drake, M.
    Ginsberg, D.
    Gruenenfelder, J.
    Moore, C.
    Kaufmann, A.
    James, C.
    Magyar, A.
    Herschorn, S.
    [J]. BJU INTERNATIONAL, 2015, 115 : 40 - 40
  • [2] ONABOTULINUMTOXINA SIGNIFICANTLY REDUCES URINARY INCONTINENCE AND IMPROVES QUALITY OF LIFE IN FEMALE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER
    Khullar, V.
    Sand, P.
    Parsons, M.
    Zhou, J.
    Globe, D.
    Nardo, C.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2013, 24 : S13 - S14
  • [3] ONABOTULINUMTOXINA IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER WITH URINARY INCONTINENCE
    Sand, P. K.
    Khalaf, K. M.
    Yan, X.
    Globe, D.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2012, 23 : S191 - S192
  • [4] TREATMENT WITH ONABOTULINUMTOXINA SIGNIFICANTLY REDUCES EPISODES OF URINARY INCONTINENCE AND IMPROVES QUALITY OF LIFE IN FEMALE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER SYNDROME
    Sand, Peter
    Parsons, Matthew
    Zhou, Jihao
    Globe, Denise
    Nardo, Christopher
    Khullar, Vik
    [J]. NEUROUROLOGY AND URODYNAMICS, 2014, 33 (02) : 209 - 209
  • [5] OnabotulinumtoxinA for Overactive Bladder and Urinary Incontinence
    Chancellor, Michael B.
    [J]. JOURNAL OF UROLOGY, 2017, 197 (02): : S224 - S236
  • [6] Impact of urinary incontinence and overactive bladder on quality of life
    Chiaffarino, F
    Parazzini, F
    Lavezzari, M
    Giambanco, V
    [J]. EUROPEAN UROLOGY, 2003, 43 (05) : 535 - 538
  • [7] ONABOTULINUMTOXINA DEMONSTRATES SIMILAR IMPROVEMENTS IN URINARY INCONTINENCE AND QUALITY OF LIFE REGARDLESS OF THE USE OF CLEAN INTERMITTENT CATHETERISATION OR THE PRESENCE OF URINARY TRACT INFECTION IN PATIENTS WITH OVERACTIVE BLADDER
    Everaert, K.
    Gruenenfelder, J.
    Schulte-Baukloh, H.
    Guard, S.
    Zheng, Y.
    Sussman, D.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2014, 33 (06) : 768 - 769
  • [8] OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
    Chapple, Christopher
    Sievert, Karl-Dietrich
    MacDiarmid, Scott
    Khullar, Vik
    Radziszewski, Piotr
    Nardo, Christopher
    Thompson, Catherine
    Zhou, Jihao
    Haag-Molkenteller, Cornelia
    [J]. EUROPEAN UROLOGY, 2013, 64 (02) : 249 - 256
  • [9] Economic impact of onabotulinumtoxinA for overactive bladder with urinary incontinence in Europe
    Ruff, Lewis
    Bagshaw, Emma
    Aracil, Javier
    Velard, Marie-Eve
    Pardhanani, Gianni
    Hepp, Zsolt
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (12) : 1107 - 1115
  • [10] LONG-TERM IMPROVEMENTS IN QUALITY OF LIFE FOLLOWING ONABOTULINUMTOXINA TREATMENT IN FEMALE PATIENTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE
    Sand, P. K.
    Khullar, V.
    Joshi, M.
    Zheng, Y.
    Nitti, V.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2014, 25 : S61 - S62
12345